Agios Pharmaceuticals Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio2.781.11
P/S Ratio51.3546.40108.35
P/B Ratio1.221.531.401.387.51
Price/Tangible Book1.221.531.401.387.51
Enterprise Value Ratios
EV/Revenue7.5116.7042.61
Profitability & Returns
Return on Equity (ROE)0.57%-0.37%-0.19%-0.42%-0.63%
Return on Assets (ROA)-0.20%-0.22%-0.18%-0.21%-0.24%
Return on Invested Capital (ROIC)-0.99%-1.54%-1.01%-2.52%-5.55%
Return on Capital Employed (ROCE)-0.27%-0.45%-0.33%-0.28%-0.44%
Leverage & Solvency Ratios
Debt/Equity0.040.090.080.070.26
Liquidity Ratios
Current Ratio11.9012.2713.3017.796.75
Quick Ratio11.0611.4912.5417.176.07
Efficiency Ratios
Asset Turnover0.030.030.01
Inventory Turnover13.0821.65
Yield & Distribution Ratios
Earnings Yield0.36%-0.28%-0.15%0.90%-0.11%
FCF Yield-0.21%-0.24%-0.20%-0.23%-0.10%
Buyback Yield-0.04%-0.02%0.09%0.12%-0.15%